Wednesday, July 8, 2026
🇺🇸 FDA

Drug profile · INN

amphetamine aspartate

DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

amphetamine aspartate (DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE) is a norepinephrine transporter releasing agent. Associated with ELITE PHARMACEUTICALS INC /NV/. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 11
Pipeline programs 7
News articles 0
Drug details — amphetamine aspartate
US status
approved
Class
—
Route
ORAL
Patents
11
Programs
7
Data quality
0.89
← All drugs Manufacturer profile Related patents Pipeline programs Drug news hub Event calendar

Quick answer

amphetamine aspartate (DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE) is a norepinephrine transporter releasing agent. Associated with ELITE PHARMACEUTICALS INC /NV/. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN amphetamine aspartate
Brand DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
Mechanism Norepinephrine transporter releasing agent
Target Sodium-dependent dopamine transporter
Route ORAL
Formulation CAPSULE, EXTENDED RELEASE
Originator ELITE PHARMACEUTICALS INC /NV/

Mechanism of action

Norepinephrine transporter releasing agent

Primary target: Sodium-dependent dopamine transporter

Approval history

Authority Status Date
FDA approved —

Pipeline programs

Search pipeline Sponsor programs
  1. Adderall-XR Phase 3 · BRIGHT MINDS BIOSCIENCES · Cannabis Use Disorder
  2. Mixed salts of a single-entity amphetamine (ADDERALL XR) Phase 3 · Takeda · ADHD
  3. SPD465-303 Phase 3 · Takeda · Attention Deficit Disorder With Hyperactivity
  4. Adderall-XR and Topiramate Phase 2 · BRIGHT MINDS BIOSCIENCES · Cocaine Dependence
  5. DEADA-07-23 Phase 1 · Anaxis Pharma · ADHD
  6. Adderall Approved · BRIGHT MINDS BIOSCIENCES · Attention Deficit Disorder With Hyperactivity
  7. Mixed amphetamine salts (ADDERALL XR) Approved · Takeda · ADHD

Related & competitor drugs

Browse all drugs
  1. amphetamine adipate Dopamine transporter releasing agent
  2. amphetamine sulfate Norepinephrine transporter releasing agent
  3. armodafinil Dopamine transporter inhibitor
  4. bupropion hydrochloride Dopamine transporter inhibitor
  5. dexmethylphenidate hydrochloride Norepinephrine transporter inhibitor
  6. dextroamphetamine sulfate Norepinephrine transporter releasing agent

Related patents

Browse patents ELITE PHARMACEUTICALS INC /NV/ patent hub

  1. US 12364693

    Methods of treating metabolic diseases with fused bicyclic pyrazoles

    Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12295394

    Water-soluble additive composition

    Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11389444

    Methods of treating metabolic diseases with fused bicyclic pyrazoles

    Expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10213388

    Abuse resistant oral dosage forms

    Expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9125822

    Particle for medical use and process for producing the same

    Expires Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9056054

    Abuse resistant oral dosage forms

    Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8703186

    Abuse-resistant oral dosage forms and method of use thereof

    Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8529257

    Aerosolized ceramic porcelains and glaze composition

    Expires Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8425933

    Abuse-resistant oral dosage forms and method of use thereof

    Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8182836

    Abuse-resistant oral dosage forms and method of use thereof

    Expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7018465

    Aerosolized ceramic porcelains and glaze composition

    Expires Mon Mar 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is amphetamine aspartate?

amphetamine aspartate (DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE) is a norepinephrine transporter releasing agent. Associated with ELITE PHARMACEUTICALS INC /NV/. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for amphetamine aspartate?

DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE is a marketed brand name for amphetamine aspartate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of amphetamine aspartate?

amphetamine aspartate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.